Synthesis, characterization and in vitro biological activity studies of Cu–M (M = Cu 2+, Co 2+, Ni 2+, Mn 2+, Zn 2+) bimetallic complexes
Six new bimetallic complexes of the type CuCu, CuCo, CuNi, CuZn and CuMn were prepared. The structures of these complexes and the ligand have been proposed on the basis of FAB mass, elemental analysis, UV–vis, IR, EPR and CV studies. All the complexes completely cleave pBS (SK−) DNA at a concentrati...
Gespeichert in:
Veröffentlicht in: | European journal of medicinal chemistry 2006-12, Vol.41 (12), p.1494-1503 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1503 |
---|---|
container_issue | 12 |
container_start_page | 1494 |
container_title | European journal of medicinal chemistry |
container_volume | 41 |
creator | Rupesh, K.R. Deepalatha, S. Krishnaveni, M. Venkatesan, R. Jayachandran, S. |
description | Six new bimetallic complexes of the type CuCu, CuCo, CuNi, CuZn and CuMn were prepared. The structures of these complexes and the ligand have been proposed on the basis of FAB mass, elemental analysis, UV–vis, IR, EPR and CV studies. All the complexes completely cleave pBS (SK−) DNA at a concentration of 10
μM; however, even at lower concentrations of 2
μM and 0.1
μM, the complexes (
I and
Ia) showed partial cleavage. The results of the fluorescence binding studies of the metal complexes with CT-DNA showed that the presence of aliphatic ligands added additional binding effects including electrostatic, hydrogen binding and vander Waals interactions. Complexes (
I,
Ia) showed 50% inhibition of COX-1 and COX-2 activities at as low a concentration as 12.5
μM, 13.5
μM, 14
μM and 14.5
μM. Inhibition assay of top I and top II by different complexes in mutant yeast strains (JN394, JN394 t
−1 and JN394 t
2–5) with all the complexes showed significant inhibition of topoisomerase at 5
μM concentration. Complexes
I and
Ia exhibited good anti-microbial activities against all human pathogens tested except
Klebsiella pneumoniae. The following studies showed that among the synthesized bimetallic complexes, complexes
I and
Ia seem to be promising candidates possessing DNA cleavage activities besides anti-microbial and anti-inflammatory properties to serve as chemical nucleases and chemotherapeutic agents.
[Display omitted] |
doi_str_mv | 10.1016/j.ejmech.2005.11.016 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68252343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523406002704</els_id><sourcerecordid>68252343</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-f64a898accadef8fcab885251811e20e4351317d5a4a8263d25558c091e427603</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EotPCGyDkDYiKJvgndtwFSGhUClIHFsCGjeVxbhiPknhqO1WHVfcseUOeBGdmpO5YHevqu8dX5yD0jJKSEirfrEtY92BXJSNElJSWefgAzWgtVcGZqB6iGWGMF4Lx6ggdx7gmGZSEPEZHtCaUyprM0O-v2yGtILp4hu3KBGMTBPfLJOcHbIYGuwHfuBQ8Xjrf-Z_Omg5nyOXhFsc0Ng4i9i2ej3_v_izwqwV-m9-YvT7Dc7-Tz24ni2EnPyY5zW49JNN1zmLr-00HtxCfoEet6SI8PegJ-v7h4tv8Y3H15fLT_P1VYSshU9HKyqhzZaw1DbSqtWaplGCCKkqBEai4oJzWjTCZY5I3TAihLDmnULFaEn6CXu59N8FfjxCT7l200HVmAD9GLRWbQuMZrPagDT7GAK3eBNebsNWU6KkEvdb7EvRUgqZU52Fee37wH5c9NPdLh9Qz8OIAmJjzbIMZrIv3nOI1l3z6_92eg5zGjYOgo3UwWGhcAJt0493_L_kHqJqjwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68252343</pqid></control><display><type>article</type><title>Synthesis, characterization and in vitro biological activity studies of Cu–M (M = Cu 2+, Co 2+, Ni 2+, Mn 2+, Zn 2+) bimetallic complexes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Rupesh, K.R. ; Deepalatha, S. ; Krishnaveni, M. ; Venkatesan, R. ; Jayachandran, S.</creator><creatorcontrib>Rupesh, K.R. ; Deepalatha, S. ; Krishnaveni, M. ; Venkatesan, R. ; Jayachandran, S.</creatorcontrib><description>Six new bimetallic complexes of the type CuCu, CuCo, CuNi, CuZn and CuMn were prepared. The structures of these complexes and the ligand have been proposed on the basis of FAB mass, elemental analysis, UV–vis, IR, EPR and CV studies. All the complexes completely cleave pBS (SK−) DNA at a concentration of 10
μM; however, even at lower concentrations of 2
μM and 0.1
μM, the complexes (
I and
Ia) showed partial cleavage. The results of the fluorescence binding studies of the metal complexes with CT-DNA showed that the presence of aliphatic ligands added additional binding effects including electrostatic, hydrogen binding and vander Waals interactions. Complexes (
I,
Ia) showed 50% inhibition of COX-1 and COX-2 activities at as low a concentration as 12.5
μM, 13.5
μM, 14
μM and 14.5
μM. Inhibition assay of top I and top II by different complexes in mutant yeast strains (JN394, JN394 t
−1 and JN394 t
2–5) with all the complexes showed significant inhibition of topoisomerase at 5
μM concentration. Complexes
I and
Ia exhibited good anti-microbial activities against all human pathogens tested except
Klebsiella pneumoniae. The following studies showed that among the synthesized bimetallic complexes, complexes
I and
Ia seem to be promising candidates possessing DNA cleavage activities besides anti-microbial and anti-inflammatory properties to serve as chemical nucleases and chemotherapeutic agents.
[Display omitted]</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2005.11.016</identifier><identifier>PMID: 17011670</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Oxford: Elsevier Masson SAS</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-microbial ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal Agents - pharmacology ; Bimetallic complexes ; Biological and medical sciences ; COX ; Cu(II) complexes ; Cyclooxygenase Inhibitors - pharmacology ; DNA - drug effects ; DNA cleavage ; General aspects ; Medical sciences ; Metals - pharmacology ; Models, Molecular ; Pharmacology. Drug treatments ; Spectrometry, Fluorescence ; Topoisomerase I Inhibitors</subject><ispartof>European journal of medicinal chemistry, 2006-12, Vol.41 (12), p.1494-1503</ispartof><rights>2006 Elsevier Masson SAS</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-f64a898accadef8fcab885251811e20e4351317d5a4a8263d25558c091e427603</citedby><cites>FETCH-LOGICAL-c456t-f64a898accadef8fcab885251811e20e4351317d5a4a8263d25558c091e427603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0223523406002704$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18373633$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17011670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rupesh, K.R.</creatorcontrib><creatorcontrib>Deepalatha, S.</creatorcontrib><creatorcontrib>Krishnaveni, M.</creatorcontrib><creatorcontrib>Venkatesan, R.</creatorcontrib><creatorcontrib>Jayachandran, S.</creatorcontrib><title>Synthesis, characterization and in vitro biological activity studies of Cu–M (M = Cu 2+, Co 2+, Ni 2+, Mn 2+, Zn 2+) bimetallic complexes</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>Six new bimetallic complexes of the type CuCu, CuCo, CuNi, CuZn and CuMn were prepared. The structures of these complexes and the ligand have been proposed on the basis of FAB mass, elemental analysis, UV–vis, IR, EPR and CV studies. All the complexes completely cleave pBS (SK−) DNA at a concentration of 10
μM; however, even at lower concentrations of 2
μM and 0.1
μM, the complexes (
I and
Ia) showed partial cleavage. The results of the fluorescence binding studies of the metal complexes with CT-DNA showed that the presence of aliphatic ligands added additional binding effects including electrostatic, hydrogen binding and vander Waals interactions. Complexes (
I,
Ia) showed 50% inhibition of COX-1 and COX-2 activities at as low a concentration as 12.5
μM, 13.5
μM, 14
μM and 14.5
μM. Inhibition assay of top I and top II by different complexes in mutant yeast strains (JN394, JN394 t
−1 and JN394 t
2–5) with all the complexes showed significant inhibition of topoisomerase at 5
μM concentration. Complexes
I and
Ia exhibited good anti-microbial activities against all human pathogens tested except
Klebsiella pneumoniae. The following studies showed that among the synthesized bimetallic complexes, complexes
I and
Ia seem to be promising candidates possessing DNA cleavage activities besides anti-microbial and anti-inflammatory properties to serve as chemical nucleases and chemotherapeutic agents.
[Display omitted]</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-microbial</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal Agents - pharmacology</subject><subject>Bimetallic complexes</subject><subject>Biological and medical sciences</subject><subject>COX</subject><subject>Cu(II) complexes</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>DNA - drug effects</subject><subject>DNA cleavage</subject><subject>General aspects</subject><subject>Medical sciences</subject><subject>Metals - pharmacology</subject><subject>Models, Molecular</subject><subject>Pharmacology. Drug treatments</subject><subject>Spectrometry, Fluorescence</subject><subject>Topoisomerase I Inhibitors</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhS0EotPCGyDkDYiKJvgndtwFSGhUClIHFsCGjeVxbhiPknhqO1WHVfcseUOeBGdmpO5YHevqu8dX5yD0jJKSEirfrEtY92BXJSNElJSWefgAzWgtVcGZqB6iGWGMF4Lx6ggdx7gmGZSEPEZHtCaUyprM0O-v2yGtILp4hu3KBGMTBPfLJOcHbIYGuwHfuBQ8Xjrf-Z_Omg5nyOXhFsc0Ng4i9i2ej3_v_izwqwV-m9-YvT7Dc7-Tz24ni2EnPyY5zW49JNN1zmLr-00HtxCfoEet6SI8PegJ-v7h4tv8Y3H15fLT_P1VYSshU9HKyqhzZaw1DbSqtWaplGCCKkqBEai4oJzWjTCZY5I3TAihLDmnULFaEn6CXu59N8FfjxCT7l200HVmAD9GLRWbQuMZrPagDT7GAK3eBNebsNWU6KkEvdb7EvRUgqZU52Fee37wH5c9NPdLh9Qz8OIAmJjzbIMZrIv3nOI1l3z6_92eg5zGjYOgo3UwWGhcAJt0493_L_kHqJqjwg</recordid><startdate>20061201</startdate><enddate>20061201</enddate><creator>Rupesh, K.R.</creator><creator>Deepalatha, S.</creator><creator>Krishnaveni, M.</creator><creator>Venkatesan, R.</creator><creator>Jayachandran, S.</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061201</creationdate><title>Synthesis, characterization and in vitro biological activity studies of Cu–M (M = Cu 2+, Co 2+, Ni 2+, Mn 2+, Zn 2+) bimetallic complexes</title><author>Rupesh, K.R. ; Deepalatha, S. ; Krishnaveni, M. ; Venkatesan, R. ; Jayachandran, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-f64a898accadef8fcab885251811e20e4351317d5a4a8263d25558c091e427603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-microbial</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal Agents - pharmacology</topic><topic>Bimetallic complexes</topic><topic>Biological and medical sciences</topic><topic>COX</topic><topic>Cu(II) complexes</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>DNA - drug effects</topic><topic>DNA cleavage</topic><topic>General aspects</topic><topic>Medical sciences</topic><topic>Metals - pharmacology</topic><topic>Models, Molecular</topic><topic>Pharmacology. Drug treatments</topic><topic>Spectrometry, Fluorescence</topic><topic>Topoisomerase I Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rupesh, K.R.</creatorcontrib><creatorcontrib>Deepalatha, S.</creatorcontrib><creatorcontrib>Krishnaveni, M.</creatorcontrib><creatorcontrib>Venkatesan, R.</creatorcontrib><creatorcontrib>Jayachandran, S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rupesh, K.R.</au><au>Deepalatha, S.</au><au>Krishnaveni, M.</au><au>Venkatesan, R.</au><au>Jayachandran, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, characterization and in vitro biological activity studies of Cu–M (M = Cu 2+, Co 2+, Ni 2+, Mn 2+, Zn 2+) bimetallic complexes</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2006-12-01</date><risdate>2006</risdate><volume>41</volume><issue>12</issue><spage>1494</spage><epage>1503</epage><pages>1494-1503</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>Six new bimetallic complexes of the type CuCu, CuCo, CuNi, CuZn and CuMn were prepared. The structures of these complexes and the ligand have been proposed on the basis of FAB mass, elemental analysis, UV–vis, IR, EPR and CV studies. All the complexes completely cleave pBS (SK−) DNA at a concentration of 10
μM; however, even at lower concentrations of 2
μM and 0.1
μM, the complexes (
I and
Ia) showed partial cleavage. The results of the fluorescence binding studies of the metal complexes with CT-DNA showed that the presence of aliphatic ligands added additional binding effects including electrostatic, hydrogen binding and vander Waals interactions. Complexes (
I,
Ia) showed 50% inhibition of COX-1 and COX-2 activities at as low a concentration as 12.5
μM, 13.5
μM, 14
μM and 14.5
μM. Inhibition assay of top I and top II by different complexes in mutant yeast strains (JN394, JN394 t
−1 and JN394 t
2–5) with all the complexes showed significant inhibition of topoisomerase at 5
μM concentration. Complexes
I and
Ia exhibited good anti-microbial activities against all human pathogens tested except
Klebsiella pneumoniae. The following studies showed that among the synthesized bimetallic complexes, complexes
I and
Ia seem to be promising candidates possessing DNA cleavage activities besides anti-microbial and anti-inflammatory properties to serve as chemical nucleases and chemotherapeutic agents.
[Display omitted]</abstract><cop>Oxford</cop><pub>Elsevier Masson SAS</pub><pmid>17011670</pmid><doi>10.1016/j.ejmech.2005.11.016</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0223-5234 |
ispartof | European journal of medicinal chemistry, 2006-12, Vol.41 (12), p.1494-1503 |
issn | 0223-5234 1768-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_68252343 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Anti-Bacterial Agents - pharmacology Anti-microbial Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal Agents - pharmacology Bimetallic complexes Biological and medical sciences COX Cu(II) complexes Cyclooxygenase Inhibitors - pharmacology DNA - drug effects DNA cleavage General aspects Medical sciences Metals - pharmacology Models, Molecular Pharmacology. Drug treatments Spectrometry, Fluorescence Topoisomerase I Inhibitors |
title | Synthesis, characterization and in vitro biological activity studies of Cu–M (M = Cu 2+, Co 2+, Ni 2+, Mn 2+, Zn 2+) bimetallic complexes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T05%3A24%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20characterization%20and%20in%20vitro%20biological%20activity%20studies%20of%20Cu%E2%80%93M%20(M%20=%20Cu%202+,%20Co%202+,%20Ni%202+,%20Mn%202+,%20Zn%202+)%20bimetallic%20complexes&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Rupesh,%20K.R.&rft.date=2006-12-01&rft.volume=41&rft.issue=12&rft.spage=1494&rft.epage=1503&rft.pages=1494-1503&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2005.11.016&rft_dat=%3Cproquest_cross%3E68252343%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68252343&rft_id=info:pmid/17011670&rft_els_id=S0223523406002704&rfr_iscdi=true |